Grants for Nonprofits - Consumer Protection

This funding opportunity supports a national initiative to educate and empower Medicare beneficiaries and their families against fraud and abuse, by providing resources and training to organizations dedicated to this mission across the U.S. and its territories.

This grant provides financial support to citrus growers in select California counties to implement sustainable farming practices that improve soil health, enhance climate resilience, and promote environmental stewardship, with a focus on assisting socially disadvantaged farmers, women, and veterans.

The Executive Office of Mayor Muriel Bowser and the Mayor’s Office of Lesbian, Gay, Bisexual, Transgender, and Questioning Affairs (MOLGBTQA) is soliciting grant applications for its FY2025 LGBTQIA+ Violence Prevention & Response Team (“VPART”) Grant from qualified community-based organizations (CBOs) serving the District of Columbia’s lesbian, gay, bisexual, transgender, gender-non-conforming, questioning, queer, intersex, sexual and gender expansive (LGBTQIA+) community. Donor Name: Mayor’s Office of LGBTQ Affairs (MOLGBTQA) State: County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/05/2024 Size of the Grant: $10,000 to $100,000 Grant Duration: 1 Year Details: MOLGBTQA convenes a monthly Violence Prevention & Response Team (“VPART”) meeting, which brings together representatives from relevant public safety and human services agencies and organizations serving the LGBTQ+ community. The aim of VPART is to prevent crime against members of the LGBTQ+ community. This grant seeks to support this mission and identify designated organizations that can coordinate the VPART team, services for LGBTQIA+ individuals who are victims of crime, and empower other CBOs by conducting training sessions for their staff and volunteers. The MOLGBTQA convenes a monthly VPART meeting with the mission to bring together community and government agencies to reduce violence and harm against members of the LGBTQIA+ community. Funding Areas  To qualify for the FY2025 LGBTQIA+ VPART Grant, applicants must identify at least one service area to be addressed: Violence Response Services or Victim Prevention Outreach. Applicants may indicate their interest in providing both services. Please specify the service area(s) for which you are applying and how your skills and experience are relevant to the needs and goals of the community. It is encouraged that applicants apply to as many services and programs as possible to demonstrate their full capacity to support the objectives of VPART. If selected for funding, applicants may be asked to focus on fewer services and programs within each area. This will depend on the number of grantees selected and how they are organized to be a part of VPART. Victim Response Services Objective: To address and mitigate violence within the LGBTQIA+ community through comprehensive support, education, and outreach.  Case Management: Assist LGBTQIA+ individuals who have been victimized and are navigating the criminal, civil legal, and social service systems. Provide assessments, planning, facilitation, and coordination to identify and access culturally and linguistically appropriate goods or services based on victims’ self-identified goals and needs.  Legal Services: Provide professional legal advice regarding one’s role in criminal proceedings.  Trauma-Informed Mental Health Services: Link individuals impacted by crime or addiction to treatment and care provided by mental health professionals. Services must be culturally appropriate, victim-centered, and delivered in a manner that is welcoming and suitable for trauma survivors. Violence Prevention Outreach Objective: To further reduce violence and harm within the LGBTQIA+ community by providing education, resources, and direct support aimed at harm reduction, recovery, and education and training.  Cultural Humility Training: Train and provide support to nonprofits, businesses, and government organizations that serve the LGBTQIA+ population throughout Washington, DC.  Community Education: Provide guidance and strategies for community members that may reduce the likelihood of physical or emotional harm. This includes conducting workshops, seminars, and public awareness campaigns.  Harm Reduction Intervention: Deliver essential harm reduction and overdose prevention resources to community members through outreach, potential establishment of support networks, and/or direct connection to addiction treatment services. Funding Information Award sizes will vary, and eligible organizations can be funded up to $50,000.  The grant will be awarded for one year starting on October 1, 2024, and ending on September 30, 2025. Target Population The target population for these funds are individuals who identify as Lesbian, Gay, Bisexual, Transgender, and Questioning, with a focus on those who are at a higher risk of being targeted by hate crimes and bias incidents. Eligibility Criteria Applicants shall meet the following conditions to apply for the FY25 LGBTQIA+ Violence Prevention & Response Grant: The organization is a CBO with a Federal 501(c)(3) tax-exempt status or evidence of fiscal agent relationship with a 501(c)(3) organization; or be a private entity, such as a coalition or association, that is partnering with at least one or more 501(c)(3) organization(s); The organization’s principal place of business must be located in the District of Columbia; if a national or regional organization, it must have a location in the District through which it provides services; The organization must provide services to DC residents or collaborate with an organization that provides services to DC residents through the organizational efforts of the applicant; The organization must be currently registered in good standing with the DC Department of Licensing and Consumer Protection (DLCP), and the Office of Tax and Revenue (OTR); All services and programming funded by the grant must be provided in the District of Columbia; For more information, visit MOLGBTQA.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

The purpose of this NOFO is: 1) To facilitate long-term improvements to the national food safety system by strengthening interagency collaboration, improving the states;apos; regulatory and surveillance protection programs for manufactured foods, conducting research, and promoting the Manufactured Food Regulatory Program Standards (MFRPS); and 2) The continued development, implementation, management, and support of a funding system for those state and territorial agencies that have primary responsibility for regulating Grade A milk or molluscan shellfish (or both). Such agencies may apply and be sub-awarded funds to facilitate training, equipment purchases, or provide for other priorities needed to implement the Grade "A" Milk Safety program and the National Shellfish Sanitation Program (NSSP) within their respective jurisdictions.

Description: The Illinois Grocery Initiative aims to establish new grocery stores in food deserts to increase access to fresh food in underserved areas. This grant, under the funding opportunity number FY24-2 and CSFA number 420-35-3295, anticipates awarding 8 grants with a total program funding of $14,000,000. Eligible projects must involve capital expenditures, as operational costs are not covered. Grants will range from $160,000 to $2,400,000, and applicants are required to meet cost-sharing requirements. The application window opens on 04/09/2024 and closes on 05/24/2024. Indirect costs are allowed but restricted to capital-only expenditures. There are mandatory and optional technical assistance sessions provided to assist applicants, with registration required through provided links.

This program provides financial support to small-scale, sustainable farms in metro Atlanta to improve their operations and enhance their contributions to the local food system.

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, companion animals (dogs, cats, and horses), and minor species (e.g., fish, sheep, goats) and 2) contribute to the development of data collection frameworks, including providing data and expertise as resources and a public-private partnership frameworks are established. This grant will support the continued advancement of FDA;apos;s initiatives to support antimicrobial stewardship in veterinary settings. It will also support the National Action Plan objectives to engage the animal health community and relevant stakeholders to advance strategies intended to improve understanding of antimicrobial use and foster antimicrobial stewardship in animal agriculture.

The "Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required" grant aims to fund clinical trials that test the effectiveness and safety of new treatments for rare diseases, with the goal of increasing the number of approved treatments for these conditions.

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled synthesis and biological activity assessment using in vitro and animal models. The proposed studies will focus on 1) synthesis of each diastereomer of LEQVIO (Inclisiran) in stereo chemically pure form; 2) assessment of the biological activity of each stereo chemically pure diastereomer in inhibiting PCSK9 activity using in vitro assays and in a transgenic mouse model; 3) development of analytical methods to identify and characterize the stereochemical structure of each diastereomer in LEQVIO; and 4) assessment of the individual contribution of each diastereomer to the overall pharmacological activity of LEQVIO. Tools developed in this research can also be applied to other similar GalNAc-conjugated siRNAs specifically, and other siRNAs in general. Knowledge gained from this research will also contribute to the sameness evaluation of generic siRNAs, and to the quality control of oligonucleotide drugs.

This grant provides financial support to organizations that participate in California Public Utilities Commission activities, helping to remove barriers to their involvement in policy decision-making processes.

This grant invites private sector companies and organizations to collaborate with USAID on projects that address economic growth, financial inclusion, and environmental sustainability, leveraging their resources and expertise to achieve shared development goals.

The ConnectALL Initiative is accepting applications for its Municipal Infrastructure Program to support the development of open-access and publicly owned and/or controlled last mile fiber broadband infrastructure to deliver reliable high-speed internet service to homes, businesses, and community anchor institutions across the state. Donor Name: ConnectALL Initiative State: New York County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/12/2024 Size of the Grant: More than $1 million Grant Duration: Grant Duration Not Mentioned Details: The mission of the New York State Urban Development Corporation d/b/a Empire State Development (“ESD”) is to promote a vigorous and growing state economy, encourage business investment and job creation, and support diverse, prosperous local economies across New York State (“NYS”) through the efficient use of loans, grants, tax credits, real estate development, marketing, and other forms of assistance. To support broadband access for communities across the state, ESD’s ConnectALL Office (“CAO”), offers a Municipal Infrastructure Program (“MIP”) Request for Applications (“RFA”).  Through this RFA, CAO intends to establish the Municipal Infrastructure Program (“MIP”) to support the development of open-access and predominantly publicly controlled last mile fiber broadband infrastructure that will directly connect homes, businesses, and community anchor institutions to reliable high-speed internet service, using funding from the U.S. Department of Treasury Capital Projects Fund (“CPF”). The objective of this RFA is to improve broadband access in communities across the state facing connectivity challenges due to the lack of affordable, high-speed internet infrastructure. Funding Information Total funding available: $228 Million Grant size: $30 million max per award Eligible Uses of Funds Eligible uses for program funding include construction of new infrastructure or acquisition of existing infrastructure under the following categories:  Last mile fiber connections to address: Last mile infrastructure: The cabling, wires, necessary pole replacements and make-ready and/or radios that ISPs use to distribute the internet from local Internet Exchanges to network and/or customer endpoints.  Drops to a building: The cabling or wires necessary to make the connection from passing fiber or cable on a street pole or in-street conduit into a building structure.  Fiber connections to Internet Exchange Points or Data Centers:  Middle mile fiber: The fiber necessary to transport internet services to a local Data Center where an Applicant is connecting its CPF-funded last mile infrastructure.  Networking equipment: The routers, switches, and other equipment necessary to interconnect networks in a Data Center.  Acquisition of existing infrastructure assets and related agreements:  Acquisition: The purchase of network assets from a public or private entity for incorporation by an Applicant into a Project Area, and related legal agreements. Eligibility Criteria Public Entities: Municipalities (cities, counties, towns, villages); Tribal Nations; state and local authorities; entities established pursuant to Section 99-y of the NYS General Municipal Law; not-for-profit entities with authorization from public entities; and regional planning boards formed under the provisions of NYS General Municipal Law. Municipal Utilities: Local government entities, including those established by a municipality as nonprofit Utility Cooperatives Eligible Private Partner Applicants, fitting one or more of the following descriptions, may submit applications with letters of endorsement from an Eligible Public Applicant. Eligible Private Partner Applicants can have an ownership structure that may be in the form of public-private partnership, private or shareholder ownership, nongovernmental nonprofit, non-utility cooperative, or community trust. Internet Service Providers (ISPs): Entities providing internet services to consumers, not limited to providers of cable television or telephone services.  Managed Service Providers (MSPs): Entities operating networks and providing service to residents and businesses by using existing internet infrastructure or partnering with construction entities to build networks.  Broadband Infrastructure Builders: Entities that construct and/or deploy open-access broadband infrastructure assets.  Broadband Infrastructure Owners: Entities that own, operate, or hold last mile or middle mile fiber infrastructure. For more information, visit ConnectALL Initiative.

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDAs stated goal of protecting public health from unacceptable risks from nitrosamine impurities in human drugs. Although significant experimental and policy/regulatory initiatives have been undertaken in this area, there remains a need for further research into and development and refinement of translational and implementable practices that will protect the public against nitrosamine risks while ensuring continued safe access to critical therapeutic drugs. The aim is to improve the safety of human drugs with potential nitrosamine impurity liabilities. In addition to the work outlined above, the award recipient will assess how best to ensure that this research and practices development continues among industry members, non-profits, and/or academic institutions once the FDA funding for this cooperative agreement ends.

The Food Safety Education Fund grants program is funded through assessments of $3 to $5 from each licensed Michigan food establishment to provide food safety training and education to consumers; and training and education to food service establishment employees and agents of the director who enforce Michigan’s food regulations (i.e., local health department sanitarians and Michigan Department of Agriculture and Rural Development food safety inspectors). Donor Name: Michigan Department of Agriculture & Rural Development (MDARD) State: Michigan County: All Counties Type of Grant: Grant Deadline: 06/24/2024 Size of the Grant: $100,000 to $500,000 Grant Duration: 1 Year Details: Funding Information Up to $365,000 is available for the 2024-2025 grant cycle for projects focused on food safety training and education. Of the $365,600, $242,500 will be available for consumer food safety education and $114,100 for education to food service establishment employees and agents of the director of MDARD. The monies that go into the fund come from assessments of $3.00 to $5.00 on food establishment licenses. Grant Period The Michigan Department of Agriculture and Rural Development (MDARD) is now accepting proposals for grants that will run from October 1, 2024, through September 30, 2025. Multi-year proposals will be considered on an individual basis, contingent on future year funding. Eligibility Criteria  The Michigan Food Law of 2000, Section 4117, directs money in the fund to be used for providing food safety training and education to consumers, food service establishment employees and agents of the director who enforce the Michigan Food Law of 2000. Applicants must be Michigan governmental and non-profit organizations and entities. Producers, marketers, processors, growers are NOT eligible for this grant opportunity. Proposals with subgrantees will be considered. Proposals should not include funding for required routine training such as HACCP or manager certification such as ServSafe. Proposal Considerations and Selection Criteria  Proposals will be scored and selected based on the following criteria: Goals/objectives to improve food safety Statewide need and audience Measurable outcomes Partnering with other organizations Matching funds Opportunities to build upon previously funded projects. For more information, visit MDARD.

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.

The U.S. Department of Agriculture (USDA), Agriculture Marketing Services (AMS), is entering into cooperative agreement with Michigan Department of Agriculture and Rural Development (MDARD) for the Resilient Food Systems Infrastructure Program Cooperative Agreements (RFSI). Donor Name: Michigan Department of Agriculture & Rural Development (MDARD) State: Michigan County: All Counties Type of Grant: Grant Deadline: 06/17/2024 Size of the Grant: $100,000 to $500,000 Grant Duration: Grant Duration Not Mentioned Details: The purpose of the Michigan RFSI program is to build resilience in the middle-of-thefood-supply-chain and strengthen local and regional food systems by creating new revenue streams for Michigan producers. MDARD will make subawards in the form of Infrastructure Grants to middle-of-the-supply businesses to create more diverse local and regional market options and create more economic opportunities for communities, allowing them to retain more of the value chain dollar. RFSI investments aim to create a food systems infrastructure to support competitive and profitable market access for domestic farm products. The program also aims to: Support development of value‐added products available to consumers; Support proposals that provide fair prices, fair wages and new and safe job opportunities that keep profits in rural communities; and Increase diversity in processing options in terms of business model approaches, geography, and availability to underserved communities. Priorities USDA intends for RFSI program to focus funding Infrastructure Grant activities that: Expand capacity for processing, aggregation, and distribution of agricultural products to create more and better markets for producers; Modernize manufacturing, tracking, storage, and information technology systems; Enhance worker safety through adoption of new technologies or investment in equipment or facility improvements; Improve the capacity of entities to comply with federal, state, and local food safety requirements; Improve operations through training opportunities; Support construction of a new facility; Modernize or expand an existing facility (including expansion and modifications to existing buildings and/or construction of new buildings at existing facilities); Construction of wastewater management structures, etc.; Modernize processing and manufacturing equipment; and Develop, customize, or install equipment that reduces greenhouse gas emissions, increases efficiency in water use, improves air and/or water quality, and/or meets one or more of USDA’s climate action goals. Funding Information Michigan has been awarded over $10 million dollars. Equipment Only Grant: These projects offer a simplified application to fund smaller grants from $10,000 up to $100,000 Infrastructure Grants: Infrastructure grants will have a maximum award of $475,000. Eligibility Criteria The following entities are eligible for Infrastructure Grants made by MDARD: Agricultural producers or processors, or groups of agricultural producers and processors Nonprofit organizations operating middle-of-the-supply-chain activities such as processing, aggregation, distribution of targeted agricultural products Local government entities operating middle-of-the-supply-chain activities such as processing, aggregation, distribution of targeted agricultural products Tribal governments operating middle-of-the-supply-chain activities such as processing, aggregation, distribution of targeted agricultural products. Institutions such as schools, universities, or hospitals bringing producers together to establish cooperative or shared infrastructure or invest in equipment that will benefit multiple producers middle-of-the-supply-chain activities such as processing, aggregation, distribution of targeted agricultural product. For more information, visit MDARD.

This funding opportunity supports researchers in developing innovative tools that can speed up drug development and improve regulatory processes, ultimately enhancing public health by facilitating faster access to effective treatments.

The California Department of Financial Protection and Innovation (DFPI) is now accepting applications for CalMoneySmart Grant Program, which will award a total of $2 million to nonprofits annually to provide free financial education and empowerment programs for people experiencing financial insecurity in California. Donor Name: Department of Financial Protection and Innovation (DFPI) State: California County: All Counties Type of Grant: Grant Deadline: 05/06/2024 Size of the Grant: $100,000 to $500,000 Grant Duration: 2 Years Details: Funding Information CalMoneySmart offers qualifying nonprofit organizations grants of up to $200,000. Grant Period Grant awards will be announced for a two-year period covering two consecutive fiscal years. Grant Funding Uses The grants may be used to: Design, develop, or offer free classroom- or web-based financial education and empowerment content intended to help unbanked and underbanked consumers achieve, identify, and access lower-cost financial products and services, establish or improve their credit, increase their savings, or lower their debt. Provide individualized, free financial coaching to unbanked and underbanked consumers. Design, develop, or offer a free financial product or service intended to help unbanked and underbanked consumers identify and access responsible financial products and financial services, establish or improve their credit, increase their savings, or lower their debt. Eligibility Criteria  To be eligible for a grant, an Applicant must meet the following criteria: The Applicant is exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code and is organized and operated exclusively for one or more of the purposes described in Section 501(c)(3) of the Internal Revenue Code; and No part of the net earnings of the Applicant shall inure to the benefit of a private shareholder or individual. The Applicant must be in good standing with the Secretary of State of California and the state of the Applicant’s incorporation, if applicable. Submission of a satisfactory final report for any and all prior grant funding awarded by DFPI. For more information, visit DFPI.

Notice of Funding Opportunity Description Background The Food and Drug Administration (FDA) protects the public health by ensuring that medical products intended to be marketed in the United States are safe and effective for their intended use. FDA stakeholders are exploring innovative ways to produce scientific evidence in support of regulatory submissions, including the development of new data sources, study designs, methodologies, and technologies. FDA encourages and facilitates the use of such innovative approaches while ensuring that the scientific evidence supporting marketing approvals meet our high evidentiary standards. The Prescription Drug User Fee Act VII (PDUFA VII) commitment letter represents the product of discussions between the FDA, regulated industry, and public stakeholders, as mandated by Congress. The performance and procedural goals and other commitments specified in the PDUFA VII commitment letter apply to aspects of the human drug review program that are important for facilitating timely access to safe, effective, and innovative new medicines for patients. The commitment letter includes goals relating to the use of digital health technologies (DHTs) to support drug development and review. A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses. DHTs for remote data acquisition in clinical investigations can include hardware and/or software to perform one or more functions. DHTs may rely on or work with other technologies that support their operation, such as general-purpose computing platforms (e.g., smartphones) and communication networks. Among other activities relating to the use of DHTs, FDA has established a Framework for the Use of DHTs in Drug and Biological Product Development to guide the use of DHT-derived data in regulatory decision-making for drugs (hereinafter Framework ). The Framework highlights FDA’s DHT efforts including workshops and demonstration projects; engagement with stakeholders; establishment of internal processes to support the evaluation of DHTs for use in drug development; promotion of shared learning and consistency regarding DHT-based policy, procedure, and analytic tool development; and publication of guidance documents. In addition, FDA’s webpage DHTs for Drug Development (available at: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development) provides an overview of the ongoing DHT efforts, including demonstration projects. A variety of project types are welcomed under this NOFO, applicable to drugs and biologics (not devices). FDA is particularly interested in projects that evaluate the use of DHTs in drug development. Project Objectives The overarching goal of this notice of funding opportunity (NOFO) is to explore the role of DHTs (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs. These projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations. The scope includes, but is not limited to, projects that focus on: Comparing digital measurements to traditional measurements in clinical trials to evaluate drugs Developing and evaluating novel endpoints using DHTs to address unmet needs for drug clinical trials (e.g., use of environmental sensors to capture apnea in pediatric patients) Comparing metrics to evaluate continuous measurements (e.g., maximum activity and stamina) Capturing early manifestations of chronic diseases (e.g., dementia) through the use of DHTs